Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension

NCT ID: NCT00095394

Last Updated: 2011-04-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

645 participants

Study Classification

INTERVENTIONAL

Study Start Date

2004-09-30

Study Completion Date

2005-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this clinical research is to learn if severe hypertension can be better controlled by initially treating with a combination of drugs (Irbesartan/HCTZ), in patients who are unlikely to achieve blood pressure (B/P) control with only one drug. In addition, the study will also evaluate the safety and tolerability of the drugs.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A1

Group Type EXPERIMENTAL

Irbesartan/HCTZ

Intervention Type DRUG

Tablets, Oral, Irbesartan 150mg/HCTZ 12.5 mg, Once daily, 7 weeks.

A2

Group Type ACTIVE_COMPARATOR

Irbesartan monotherapy

Intervention Type DRUG

Tablets, Oral, 150 mg, Once daily, 7 weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Irbesartan/HCTZ

Tablets, Oral, Irbesartan 150mg/HCTZ 12.5 mg, Once daily, 7 weeks.

Intervention Type DRUG

Irbesartan monotherapy

Tablets, Oral, 150 mg, Once daily, 7 weeks.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Avapro Avapro

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men and women ages 18 and older;
* Willing to provide written informed consent;
* Must have uncontrolled hypertension defined as: currently untreated with a diastolic blood pressure greater than 110 mmHg OR currently receiving antihypertensive monotherapy with a diastolic blood pressure greater than 100 mmHg. Monotherapy is defined as treatment with one antihypertensive medication for at least four weeks; fixed combination therapy does not represent monotherapy;
* Must be willing to discontinue antihypertensive medication, if applicable;
* Women of childbearing potential (WOCBP) must be using an adequate method of contraception to avoid pregnancy throughout the study and for up to one week after the study in such a manner that the risk of pregnancy is minimized.
* WOCBP must have a negative serum or urine pregnancy test within 72 hours prior to the start of study medication.

Exclusion Criteria

* Women who are pregnant or breastfeeding;
* Known or suspected secondary hypertension;
* Hypertension emergencies or stroke within the past 12 months;
* Heart attack, angina or bypass surgery within the past 6 months;
* Significant kidney disease;
* Significant liver disease;
* Systemic lupus erythematosus;
* Gastrointestinal disease or surgery that may interfere with drug absorption;
* Cancer during the past five years excluding localized squamous cell or basal cell carcinoma of the skin;
* Currently pregnant or lactating;
* Mental condition (psychiatric or organic cerebral disease) rendering the subject unable to understand the nature, scope, and possible consequences of the study;
* Drug or alcohol abuse within the last five years;
* Known allergy to irbesartan or diuretics.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sanofi

INDUSTRY

Sponsor Role collaborator

Bristol-Myers Squibb

INDUSTRY

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bristol-Myers Squibb

Role: STUDY_DIRECTOR

Bristol-Myers Squibb

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Local Institution

Birmingham, Alabama, United States

Site Status

Local Institution

Columbiana, Alabama, United States

Site Status

Local Institution

Huntsville, Alabama, United States

Site Status

Local Institution

Mesa, Arizona, United States

Site Status

Local Institution

Phoenix, Arizona, United States

Site Status

Local Institution

Scottsdale, Arizona, United States

Site Status

Local Institution

Sherwood, Arkansas, United States

Site Status

Local Institution

Carlsbad, California, United States

Site Status

Local Institution

Carmichael, California, United States

Site Status

Local Institution

Corona, California, United States

Site Status

Local Institution

Encinitas, California, United States

Site Status

Local Institution

Fresno, California, United States

Site Status

Local Institution

Laguna Hills, California, United States

Site Status

Local Institution

Long Beach, California, United States

Site Status

Local Institution

Mission Hills, California, United States

Site Status

Local Institution

Raleigh, California, United States

Site Status

Local Institution

Redondo Beach, California, United States

Site Status

Local Institution

Rolling Hills Estate, California, United States

Site Status

Local Institution

Roseville, California, United States

Site Status

Local Institution

Sacramento, California, United States

Site Status

Local Institution

San Diego, California, United States

Site Status

Local Institution

San Jose, California, United States

Site Status

Local Institution

Santa Ana, California, United States

Site Status

Local Institution

Torrance, California, United States

Site Status

Local Institution

Tustin, California, United States

Site Status

Local Institution

Boulder, Colorado, United States

Site Status

Local Institution

Denver, Colorado, United States

Site Status

Local Institution

Highlands Ranch, Colorado, United States

Site Status

Local Institution

Wheat Ridge, Colorado, United States

Site Status

Local Institution

Bridgeport, Connecticut, United States

Site Status

Local Institution

Waterbury, Connecticut, United States

Site Status

Local Institution

Newark, Delaware, United States

Site Status

Local Institution

Charlotte Harbour, Florida, United States

Site Status

Local Institution

Chipley, Florida, United States

Site Status

Local Institution

Clearwater, Florida, United States

Site Status

Local Institution

Cocoa Beach, Florida, United States

Site Status

Local Institution

Crestview, Florida, United States

Site Status

Local Institution

DeLand, Florida, United States

Site Status

Local Institution

Hollywood, Florida, United States

Site Status

Local Institution

Jacksonville, Florida, United States

Site Status

Local Institution

Jupiter, Florida, United States

Site Status

Local Institution

Miami, Florida, United States

Site Status

Local Institution

Niceville, Florida, United States

Site Status

Local Institution

North Miami Beach, Florida, United States

Site Status

Local Institution

Ocala, Florida, United States

Site Status

Local Institution

Ocoee, Florida, United States

Site Status

Local Institution

Pembroke Pines, Florida, United States

Site Status

Local Institution

Port Orange, Florida, United States

Site Status

Local Institution

Saint Cloud, Florida, United States

Site Status

Local Institution

Sarasota, Florida, United States

Site Status

Local Institution

Tamarac, Florida, United States

Site Status

Local Institution

Tampa, Florida, United States

Site Status

Local Institution

Vero Beach, Florida, United States

Site Status

Local Institution

Zephyrhills, Florida, United States

Site Status

Local Institution

Atlanta, Georgia, United States

Site Status

Local Institution

Chicago, Illinois, United States

Site Status

Local Institution

Peoria, Illinois, United States

Site Status

Local Institution

Vernon Hills, Illinois, United States

Site Status

Local Institution

Des Moines, Iowa, United States

Site Status

Local Institution

Kansas City, Kansas, United States

Site Status

Local Institution

Wichita, Kansas, United States

Site Status

Local Institution

Erlanger, Kentucky, United States

Site Status

Local Institution

Richmond, Kentucky, United States

Site Status

Local Institution

Chalmette, Louisiana, United States

Site Status

Local Institution

New Orleans, Louisiana, United States

Site Status

Local Institution

Baltimore, Maryland, United States

Site Status

Local Institution

Elkton, Maryland, United States

Site Status

Local Institution

Oxon Hill, Maryland, United States

Site Status

Local Institution

Ayer, Massachusetts, United States

Site Status

Local Institution

Springfield, Massachusetts, United States

Site Status

Local Institution

Sudbury, Massachusetts, United States

Site Status

Local Institution

Livonia, Michigan, United States

Site Status

Local Institution

Saginaw, Michigan, United States

Site Status

Local Institution

Cleveland, Mississippi, United States

Site Status

Local Institution

Olive Branch, Mississippi, United States

Site Status

Local Institution

Picayune, Mississippi, United States

Site Status

Local Institution

Manchester, Missouri, United States

Site Status

Local Institution

St Louis, Missouri, United States

Site Status

Local Institution

Butte, Montana, United States

Site Status

Local Institution

Missoula, Montana, United States

Site Status

Local Institution

Omaha, Nebraska, United States

Site Status

Local Institution

Las Vegas, Nevada, United States

Site Status

Local Institution

Dover, New Hampshire, United States

Site Status

Local Institution

Hillsborough, New Jersey, United States

Site Status

Local Institution

South Bound Brook, New Jersey, United States

Site Status

Local Institution

Albuquerque, New Mexico, United States

Site Status

Local Institution

Buffalo, New York, United States

Site Status

Local Institution

East Syracuse, New York, United States

Site Status

Local Institution

Fulton, New York, United States

Site Status

Local Institution

Lake Success, New York, United States

Site Status

Local Institution

Mount Vernon, New York, United States

Site Status

Local Institution

New York, New York, United States

Site Status

Local Institution

Olean, New York, United States

Site Status

Local Institution

The Bronx, New York, United States

Site Status

Local Institution

Charlotte, North Carolina, United States

Site Status

Local Institution

Gastonia, North Carolina, United States

Site Status

Local Institution

Greensboro, North Carolina, United States

Site Status

Local Institution

High Point, North Carolina, United States

Site Status

Local Institution

Mint Hill, North Carolina, United States

Site Status

Local Institution

Nashville, North Carolina, United States

Site Status

Local Institution

Wilmington, North Carolina, United States

Site Status

Local Institution

Winston-Salem, North Carolina, United States

Site Status

Local Institution

Canton, Ohio, United States

Site Status

Local Institution

Cincinnati, Ohio, United States

Site Status

Local Institution

Columbus, Ohio, United States

Site Status

Local Institution

Genoa, Ohio, United States

Site Status

Local Institution

Kettering, Ohio, United States

Site Status

Local Institution

Lyndhurst, Ohio, United States

Site Status

Local Institution

Perrysburg, Ohio, United States

Site Status

Local Institution

Oklahoma City, Oklahoma, United States

Site Status

Local Institution

Tulsa, Oklahoma, United States

Site Status

Local Institution

Eugene, Oregon, United States

Site Status

Local Institution

Medford, Oregon, United States

Site Status

Local Institution

Orangeburg, Oregon, United States

Site Status

Local Institution

Portland, Oregon, United States

Site Status

Local Institution

Bensalem, Pennsylvania, United States

Site Status

Local Institution

Camp Hill, Pennsylvania, United States

Site Status

Local Institution

Collegeville, Pennsylvania, United States

Site Status

Local Institution

Levittown, Pennsylvania, United States

Site Status

Local Institution

Penndel, Pennsylvania, United States

Site Status

Local Institution

Philadelphia, Pennsylvania, United States

Site Status

Local Institution

West Grove, Pennsylvania, United States

Site Status

Local Institution

Cranston, Rhode Island, United States

Site Status

Local Institution

Charleston, South Carolina, United States

Site Status

Local Institution

Columbia, South Carolina, United States

Site Status

Local Institution

Landrum, South Carolina, United States

Site Status

Local Institution

Prosperity, South Carolina, United States

Site Status

Local Institution

Saluda, South Carolina, United States

Site Status

Local Institution

Simpsonville, South Carolina, United States

Site Status

Local Institution

Summerville, South Carolina, United States

Site Status

Local Institution

Bartlett, Tennessee, United States

Site Status

Local Institution

Bristol, Tennessee, United States

Site Status

Local Institution

Cordova, Tennessee, United States

Site Status

Local Institution

Hendersonville, Tennessee, United States

Site Status

Local Institution

Johnson City, Tennessee, United States

Site Status

Local Institution

Morristown, Tennessee, United States

Site Status

Local Institution

Nashville, Tennessee, United States

Site Status

Local Institution

New Tazewell, Tennessee, United States

Site Status

Local Institution

Selmer, Tennessee, United States

Site Status

Local Institution

Austin, Texas, United States

Site Status

Local Institution

Colleyville, Texas, United States

Site Status

Local Institution

Dallas, Texas, United States

Site Status

Local Institution

Lake Jackson, Texas, United States

Site Status

Local Institution

Midland, Texas, United States

Site Status

Local Institution

San Antonio, Texas, United States

Site Status

Local Institution

The Colony, Texas, United States

Site Status

Local Institution

Salt Lake City, Utah, United States

Site Status

Local Institution

Burke, Virginia, United States

Site Status

Local Institution

Charlottesville, Virginia, United States

Site Status

Local Institution

Hampton, Virginia, United States

Site Status

Local Institution

Norfolk, Virginia, United States

Site Status

Local Institution

Lacey, Washington, United States

Site Status

Local Institution

Olympia, Washington, United States

Site Status

Local Institution

Spokane, Washington, United States

Site Status

Local Institution

Madison, Wisconsin, United States

Site Status

Local Institution

Milwaukee, Wisconsin, United States

Site Status

Local Institution

Huy, Luik, Belgium

Site Status

Local Institution

Antwerp, , Belgium

Site Status

Local Institution

Brussels, , Belgium

Site Status

Local Institution

Edegem, , Belgium

Site Status

Local Institution

Genk, , Belgium

Site Status

Local Institution

Hasselt, , Belgium

Site Status

Local Institution

La Louvière, , Belgium

Site Status

Local Institution

Liège, , Belgium

Site Status

Local Institution

Roeselare, , Belgium

Site Status

Local Institution

Wilrijk, , Belgium

Site Status

Local Institution

Edmonton, Alberta, Canada

Site Status

Local Institution

Red Deer, Alberta, Canada

Site Status

Local Institution

Coquitlam, British Columbia, Canada

Site Status

Local Institution

North Vancouver, British Columbia, Canada

Site Status

Local Institution

Quesnel, British Columbia, Canada

Site Status

Local Institution

Sidney, British Columbia, Canada

Site Status

Local Institution

Winnipeg, Manitoba, Canada

Site Status

Local Institution

St. John's, Newfoundland and Labrador, Canada

Site Status

Local Institution

Halifax, Nova Scotia, Canada

Site Status

Local Institution

Aylmer, Ontario, Canada

Site Status

Local Institution

Burlington, Ontario, Canada

Site Status

Local Institution

Hamilton, Ontario, Canada

Site Status

Local Institution

London, Ontario, Canada

Site Status

Local Institution

Markham, Ontario, Canada

Site Status

Local Institution

Niagra Falls, Ontario, Canada

Site Status

Local Institution

Oakville, Ontario, Canada

Site Status

Local Institution

Oshawa, Ontario, Canada

Site Status

Local Institution

Richmond Hill, Ontario, Canada

Site Status

Local Institution

Sarnia, Ontario, Canada

Site Status

Local Institution

Thornhill, Ontario, Canada

Site Status

Local Institution

Toronto, Ontario, Canada

Site Status

Local Institution

Windsor, Ontario, Canada

Site Status

Local Institution

Montague, Prince Edward Island, Canada

Site Status

Local Institution

Bonaventure, Quebec, Canada

Site Status

Local Institution

Chandler, Quebec, Canada

Site Status

Local Institution

Chicoutimi, Quebec, Canada

Site Status

Local Institution

Drummondville, Quebec, Canada

Site Status

Local Institution

Greenfield Park, Quebec, Canada

Site Status

Local Institution

Montreal, Quebec, Canada

Site Status

Local Institution

Saint-Lambert, Quebec, Canada

Site Status

Local Institution

Ste-Foy, Quebec, Canada

Site Status

Local Institution

Saskatoon, Saskatchewan, Canada

Site Status

Local Institution

Ambrières-les-Vallées, , France

Site Status

Local Institution

Angers, , France

Site Status

Local Institution

Bagneux, , France

Site Status

Local Institution

Bouère, , France

Site Status

Local Institution

Château-Gontier, , France

Site Status

Local Institution

Cherbourg, , France

Site Status

Local Institution

Équeurdreville-Hainneville, , France

Site Status

Local Institution

Évron, , France

Site Status

Local Institution

La Glacerie, , France

Site Status

Local Institution

La Rochelle, , France

Site Status

Local Institution

Laval, , France

Site Status

Local Institution

Le Lion-dAngers, , France

Site Status

Local Institution

Longue, , France

Site Status

Local Institution

Longué-Jumelles, , France

Site Status

Local Institution

Louverné, , France

Site Status

Local Institution

Mayenne, , France

Site Status

Local Institution

Nieul-sur-Mer, , France

Site Status

Local Institution

Noyant, , France

Site Status

Local Institution

Sainte-Suzanne, , France

Site Status

Local Institution

Saumur, , France

Site Status

Local Institution

Villebernier, , France

Site Status

Local Institution

Spaichingen, Baden-Wurttembe, Germany

Site Status

Local Institution

Loxstedt, Niedersach, Germany

Site Status

Local Institution

Beckum, , Germany

Site Status

Local Institution

Berlin, , Germany

Site Status

Local Institution

Blankenhain, , Germany

Site Status

Local Institution

Essen, , Germany

Site Status

Local Institution

Flörsheim, , Germany

Site Status

Local Institution

Frankfurt, , Germany

Site Status

Local Institution

Fürth, , Germany

Site Status

Local Institution

Georgsmarienhütte, , Germany

Site Status

Local Institution

Germersheim, , Germany

Site Status

Local Institution

Hamburg, , Germany

Site Status

Local Institution

Hanover, , Germany

Site Status

Local Institution

Krombach, , Germany

Site Status

Local Institution

Künzing, , Germany

Site Status

Local Institution

Lambrecht, , Germany

Site Status

Local Institution

Mainburg, , Germany

Site Status

Local Institution

Mannheim, , Germany

Site Status

Local Institution

Messkirch, , Germany

Site Status

Local Institution

Monheim, , Germany

Site Status

Local Institution

Nuremberg, , Germany

Site Status

Local Institution

Parsberg, , Germany

Site Status

Local Institution

Pforzheim, , Germany

Site Status

Local Institution

Stuttgart, , Germany

Site Status

Local Institution

Villingen-Schwenningen, , Germany

Site Status

Local Institution

Waldbrunn, , Germany

Site Status

Local Institution

Welver, , Germany

Site Status

Local Institution

Beersheba, , Israel

Site Status

Local Institution

Haifa, , Israel

Site Status

Local Institution

Holon, , Israel

Site Status

Local Institution

Jerusalem, , Israel

Site Status

Local Institution

Kfar Saba, , Israel

Site Status

Local Institution

Matan, , Israel

Site Status

Local Institution

Tel Litwinsky, , Israel

Site Status

Local Institution

Ẕerifin, , Israel

Site Status

Local Institution

Beek en Donk, , Netherlands

Site Status

Local Institution

Eindhoven, , Netherlands

Site Status

Local Institution

Hardenberg, , Netherlands

Site Status

Local Institution

Heerlen, , Netherlands

Site Status

Local Institution

Lichtenvoorde, , Netherlands

Site Status

Local Institution

Rijswyk Zh, , Netherlands

Site Status

Local Institution

The Hague, , Netherlands

Site Status

Local Institution

Tilburg, , Netherlands

Site Status

Local Institution

Venlo, , Netherlands

Site Status

Local Institution

Waalwijk, , Netherlands

Site Status

Local Institution

Woerden, , Netherlands

Site Status

Local Institution

Zeist, , Netherlands

Site Status

Local Institution

Moscow, , Russia

Site Status

Local Institution

Saint Petersburg, , Russia

Site Status

Local Institution

Saratov, , Russia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Belgium Canada France Germany Israel Netherlands Russia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CV131-176

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

APROVE : Irbesartan in Hypertension
NCT00283036 COMPLETED PHASE4